The Dow’s Two Most Watched Averages Are Sending Completely Different Signals. One of Them Is LyingApril 20, 2026
Michael Saylor’s Strategy Bought $330 Million More in Bitcoin. His Conviction Has Never WaveredApril 20, 2026
The Alzheimer’s Drug That Failed Every Clinical Trial Just Succeeded in the Most Unexpected Way News March 31, 2026 The scientific community let out a collective sigh in March 2019 that was more akin to defeat than disappointment. The…
